OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy
Xiaodi Du, Hongyu Song, Nengxing Shen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3440-3440
Open Access | Times Cited: 23

Showing 23 citing articles:

Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism
Seo-Young Koo, Eun‐Ji Park, Hyun-Ji Noh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8441-8441
Open Access | Times Cited: 18

UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?
Florian Schwalen, Côme Ghadi, Léonie Ibazizene, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis
Simin Qi, Xiaoqing Guan, Jia Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 24

Ubiquitin recruiting chimera: more than just a PROTAC
Tatyana A. Grigoreva, Daria Novikova, Gerry Melino, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3

E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers
Shu‐Chun Chang, Bo-Xiang Zhang, Jeak Ling Ding
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188679-188679
Open Access | Times Cited: 17

Role of UBE2C in Brain Cancer Invasion and Dissemination
Stefani Domentean, Eunice Paisana, Rita Cascão, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15792-15792
Open Access | Times Cited: 7

Recent progress in dissecting ubiquitin signals with chemical biology tools
Qingyun Zheng, Zhen Su, Yuanyuan Yu, et al.
Current Opinion in Chemical Biology (2022) Vol. 70, pp. 102187-102187
Closed Access | Times Cited: 11

Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma
Dianke Li, Huansha Yu, Junjie Hu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11

Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions
Linjie Li, Song Liu, Youfu Luo
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116394-116394
Closed Access | Times Cited: 1

Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
Khaa Hoo Ong, Hong-Yue Lai, Ding‐Ping Sun, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4

Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes
Jerry Vriend, Thatchawan Thanasupawat, Namita Sinha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12330-12330
Open Access | Times Cited: 6

Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, et al.
Oncology Reports (2023) Vol. 49, Iss. 3
Open Access | Times Cited: 3

Blood RNA‐sequencing analysis in acrylamide‐induced neurotoxicity and depressive symptoms in rats
Yng‐Tay Chen, Tzu‐Jung Lin, Chia‐Yu Hung
Environmental Toxicology (2023) Vol. 39, Iss. 4, pp. 2316-2325
Closed Access | Times Cited: 3

UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 638, pp. 210-218
Open Access | Times Cited: 5

Integrated analysis of mRNA and microRNA expression profiles in hepatopancreas of Litopenaeus vannamei under acute exposure to MC-LR
Dajuan Zhang, Lanying Huang, Jia Ying-xuan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2

Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality
Qianqian Guo, Hai Qin, Zelong Chen, et al.
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101311-101311
Open Access

A Multiomics, Molecular Atlas of Breast Cancer Survivors
Brent A. Bauer, Caleb M. Schmidt, Kathryn J. Ruddy, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 396-396
Open Access

UBE2Q1 as a novel cancer biomarker for lung adenocarcinoma
Wei Jiang, Yuchao Wang, Jue Zou, et al.
The American Journal of the Medical Sciences (2024)
Closed Access

Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation
Mahmoud A. Desouky, Haidy E. Michel, Doaa A. Elsherbiny, et al.
Life Sciences (2024) Vol. 359, pp. 123206-123206
Closed Access

Ubiquitination-Binding Enzyme 2C is Associated with Cancer Development and Prognosis and is a Potential Therapeutic Target
Mengjie Zhao, J. Li, Rui Wang, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 1159-1171
Open Access

In silico de novo drug design of a therapeutic peptide inhibitor against UBE2C in breast cancer
Andrea Mae Añonuevo, Marineil C. Gomez, Lemmuel L. Tayo
Journal of Bioinformatics and Computational Biology (2022) Vol. 21, Iss. 01
Open Access | Times Cited: 2

UBE2S targets RPL26 for ubiquitination and degradation to promote non-small cell lung cancer progression via regulating c-Myc.
Dalian Gong, Xinxu Rao, Ziqian Min, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3705-3720
Closed Access

Page 1

Scroll to top